Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease
Abroad (travel likely)RecruitingPHASE2
Conditions
Fibrotic Interstitial Lung Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Clinical Physiology Laboratory, Edmonton, Alberta, Canada
Contact: Study coordinator (Michael K Stickland, PhD) · michael.stickland@ualberta.ca · 780-492-3995
Study leads
Mike Stickland
Principal Investigator
University of Alberta